Clinical trial · Observational
The Effects of Uterine Fibroids on Pregnancy in Women
NCT06020924CI-TRIAL-00069251unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Female fertility may be affected by uterine fibroids, although this association has not been elucidated. This retrospective cohort study aims to evaluate the impact of fibroids on women fertility.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Female Infertility | — | UNRESOLVED | — |
| Uterine Fibroid | Uterine Corpus Leiomyoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- UFs with infertile patients
- description
- Uterine fibroids combined with infertile women
- interventionNames
- Other: No intervention
- label
- UFs with non-infertile patients
- description
- Uterine fibroids combined with non-infertile women
- interventionNames
- Other: No intervention
Primary outcomes (1)
- measure
- The pregnancy rate varies with different types and size of fibroids.
- timeFrame
- through study completion, an average of 2.5 year
- description
- Fibroid types range from 0 to 8 according to the FIGO classification. The pregnancy rate varies with different types and size of fibroids. Subserosal fibroids do not exert any detrimental effects on fertility outcomes. Submucosal fibroids have negatively impact fertility. The effect of intramural fibroids on reproductive outcome has been a subject of debate in the past, but recent literature indicates that intramural myomas also negative impact fertility.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age: 20-50 years 2. Diagnosed with uterine fibroids (by ultrasound or pathology) combined with infertile or non-infertile patients 3. Complete clinical data. Exclusion Criteria: 1. Severe infectious disease or rheumatic immune disease active stage 2. Previous history of malignant tumors 3. Incomplete clinical data.
References
Publications (0)
Data not yet available
No reference posted for this study.